INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 US$
0,00%
(0,00) 1D
1,43 US$
0,00% (0,00)
todayPre-market
Closed: 13 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Mkt. cap
267,85 მლნ.
Avg. vol.
19,34 მლნ.
Volume
100,82 ათ.
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-0,80 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
Mkt. cap
267,85 მლნ.
Avg. vol.
19,34 მლნ.
Volume
100,82 ათ.
52-wk high
2,72 US$
52-wk low
0,56 US$
EPS
-0,80 US$
Beta
1,71
Shares outstanding
187,31 მლნ.
No. of employees
112
News stories
From web sources and news partners
Kitco
·
1 საათის წინ
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Barron's
·
1 საათის წინ
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
Investing.com
·
2 საათის წინ
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
FXEmpire
·
53 წუთის წინ
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc